Umecrine Cognition presents data at World Parkinson Congress showing positive effects of golexanolone in a preclinical model of Parkinson’s disease
Stockholm, July 5, 2023 – Umecrine Cognition AB today announced that results from a study on a preclinical model of Parkinson’s disease are being presented as a poster at the 6th World Parkinson…